These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Inhibition by Ca2+ of the incorporation of myo-inositol into phosphatidylinositol.
    Author: Egawa K, Takenawa T, Sacktor B.
    Journal: Mol Cell Endocrinol; 1981 Jan; 21(1):29-35. PubMed ID: 6259001.
    Abstract:
    The incorporation of myo-[2-3H]inositol into phosphatidylinositol of the aorta and the vas deferens was measured and the effects of Ca2+ and other divalent cations were determined. When incubated in normal Krebs-Ringer buffer, only negligible radioactivity was incorporated into aorta slices. Mn2+ increased the incorporation greatly. The enhanced incorporation was attributable to an increase in CDP-diglyceride:inositol transferase activity, rather than the myo-inositol exchange reaction. Transferase activity was increased 20-fold by 1 mM Mn2+, in the presence of 20 mM Mg2+. The Mn2+-stimulated activity was strongly inhibited by Ca2+. In the absence of Mn2+, but presence of 20 mM Mg2+, transferase activity was inhibited 80% by 0.01 mM Ca2+. Removal of endogenous Ca2+ from the tissue by ionophore A23187 and EGTA increased the incorporation of myo-[2-3H]inositol into phosphatidylinositol. These findings indicate that Ca2+ inhibited the synthesis of phosphatidylinositol. The proposed action of cholinergic and alpha-adrenergic agonists in enhancing the degradation and turnover of phosphatidyl-inositol and in provoking the influx of Ca2+ should be unfavorable to the recovery of cellular phosphatidylinositol content.
    [Abstract] [Full Text] [Related] [New Search]